Equities

Mizuho Medy Co Ltd

4595:TYO

Mizuho Medy Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,617.00
  • Today's Change5.00 / 0.31%
  • Shares traded12.70k
  • 1 Year change-9.66%
  • Beta1.9844
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

  • Revenue in JPY (TTM)10.99bn
  • Net income in JPY3.50bn
  • Incorporated1977
  • Employees180.00
  • Location
    Mizuho Medy Co Ltd5-4, Fujinoki-machiTOSU-SHI 841-0048JapanJPN
  • Phone+81 942850303
  • Fax+81 942850312
  • Websitehttps://www.mizuho-m.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Techno Medica Co Ltd10.34bn1.19bn15.86bn237.0010.830.922112.181.53167.16167.161,442.431,962.830.60312.254.4543,647,340.006.966.688.047.8049.9848.8611.5312.314.51159.09--39.339.781.9617.154.190.71687.67
Daiken Medical Co Ltd9.84bn1.06bn16.05bn175.0013.661.9912.501.6336.8936.89342.51253.630.86933.903.8756,226,790.009.367.4413.2510.8441.3341.7410.779.281.90301.850.252771.356.713.0138.843.03-4.010.9806
Japan Medical Dynamic Marketing, INC.24.04bn1.41bn16.12bn511.0011.390.64625.310.670653.4953.49913.02942.480.78060.67184.5347,051,430.004.716.515.447.5363.4166.976.048.881.82--0.089518.338.786.74-10.68-8.52-2.959.24
Medical Data Vision Co Ltd6.06bn4.79m16.61bn262.003,308.884.25232.372.740.12540.1254158.5997.571.12252.238.5323,120,150.00-0.465216.16-0.636720.8875.6881.90-0.414715.522.594.570.0019.985.1512.4012.4869.75-23.95--
Medius Holdings Co Ltd268.79bn1.11bn17.39bn2.52k15.570.89485.820.064750.2450.2412,186.68873.942.4918.804.97106,790,700.001.031.733.986.3411.9111.830.41120.65650.9191--0.563728.328.675.62-24.92--16.488.45
Japan Tissue Engineering Co., Ltd.2.43bn-70.51m20.10bn211.00--3.43267.388.27-1.74-1.7459.82144.180.36634.635.3811,513,990.00-1.06-4.72-1.19-5.3163.2957.30-2.90-16.387.97-295.27----23.701.29119.63--30.22--
Findex Inc6.03bn1.32bn21.45bn290.0015.623.9215.293.5651.6051.60234.94205.651.076.885.6720,784,770.0023.5715.7225.9818.4163.0256.8121.9314.588.30----36.2014.327.5846.5421.62-3.3411.63
Rion Co Ltd26.67bn2.59bn30.55bn1.03k11.761.018.321.15210.52210.522,165.882,443.260.72271.734.1225,990,020.007.036.278.177.2550.4050.299.728.852.41----28.117.793.8647.395.7825.244.56
Mizuho Medy Co Ltd10.99bn3.50bn30.81bn180.008.811.918.292.80183.56183.56576.85846.830.59721.692.6061,046,260.0019.0131.4621.2539.7871.8874.8531.8333.647.62--0.0034.83-37.4911.34-51.8532.64-17.7432.85
Nippon Care Supply Co., Ltd.30.49bn1.67bn31.21bn1.33k17.851.843.751.02107.69107.691,962.131,045.341.21119.7527.3122,853,900.006.657.619.629.9435.2037.585.496.780.6264--0.160556.7510.4310.474.212.0724.048.76
Win-Partners Co Ltd80.84bn1.98bn38.53bn629.0018.231.5817.640.476669.2969.292,830.28798.131.8824.194.87128,518,700.004.604.398.318.0612.2812.502.452.681.68----63.188.762.01-10.33-7.0140.619.34
Data as of Nov 15 2024. Currency figures normalised to Mizuho Medy Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

2.06%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 03 Oct 2024127.30k0.67%
Mellon Investments Corp.as of 03 Oct 202493.00k0.49%
American Century Investment Management, Inc.as of 03 Oct 202472.00k0.38%
BlackRock Fund Advisorsas of 02 Oct 202448.90k0.26%
PayPay Asset Management Corp.as of 10 May 202315.20k0.08%
Lazard Asset Management LLCas of 31 Dec 202312.80k0.07%
Asset Management One Co., Ltd.as of 03 Oct 20247.70k0.04%
Dimensional Fund Advisors Ltd.as of 03 Oct 20247.22k0.04%
DFA Australia Ltd.as of 30 Sep 20245.01k0.03%
Acadian Asset Management LLCas of 31 Jul 20242.60k0.01%
More ▼
Data from 26 Feb 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.